Annual FCF
$74.66 M
+$89.66 M+597.75%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual free cash flow is $74.66 million, with the most recent change of +$89.66 million (+597.75%) on December 31, 2023.
- During the last 3 years, VYGR annual FCF has risen by +$183.48 million (+168.62%).
- VYGR annual FCF is now at all-time high.
Performance
VYGR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$28.23 M
+$4.32 M+13.28%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly free cash flow is -$28.23 million, with the most recent change of +$4.32 million (+13.28%) on September 30, 2024.
- Over the past year, VYGR quarterly FCF has dropped by -$3.71 million (-15.14%).
- VYGR quarterly FCF is now -122.75% below its all-time high of $124.06 million, reached on March 31, 2019.
Performance
VYGR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$28.66 M
-$6.39 M-28.71%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM free cash flow is -$28.66 million, with the most recent change of -$6.39 million (-28.71%) on September 30, 2024.
- Over the past year, VYGR TTM FCF has dropped by -$103.33 million (-138.39%).
- VYGR TTM FCF is now -131.38% below its all-time high of $91.35 million, reached on June 30, 2023.
Performance
VYGR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VYGR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +597.8% | -15.1% | -138.4% |
| 3 y3 years | +168.6% | -114.2% | -91.1% |
| 5 y5 years | +469.8% | -114.2% | -91.1% |
VYGR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +235.4% | -122.9% | +13.3% | -131.4% | +48.0% |
| 5 y | 5-year | at high | +168.6% | -122.9% | +13.3% | -131.4% | +74.7% |
| alltime | all time | at high | +168.6% | -122.8% | +16.1% | -131.4% | +74.7% |
Voyager Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.23 M(-13.3%) | -$28.66 M(+28.7%) |
| Jun 2024 | - | -$32.55 M(-157.5%) | -$22.27 M(-370.5%) |
| Mar 2024 | - | $56.63 M(-331.0%) | $8.23 M(-89.0%) |
| Dec 2023 | $74.66 M(-597.8%) | -$24.52 M(+12.3%) | $74.66 M(-13.2%) |
| Sep 2023 | - | -$21.83 M(+967.6%) | $86.00 M(-5.9%) |
| Jun 2023 | - | -$2.04 M(-101.7%) | $91.35 M(+24.0%) |
| Mar 2023 | - | $123.06 M(-1033.9%) | $73.67 M(-591.1%) |
| Dec 2022 | -$15.00 M(-72.8%) | -$13.18 M(-20.1%) | -$15.00 M(-266.2%) |
| Sep 2022 | - | -$16.48 M(-16.4%) | $9.03 M(+118.0%) |
| Jun 2022 | - | -$19.73 M(-157.4%) | $4.14 M(+348.5%) |
| Mar 2022 | - | $34.39 M(+217.0%) | $923.00 K(-101.7%) |
| Dec 2021 | -$55.13 M(-49.3%) | $10.85 M(-150.8%) | -$55.13 M(-39.8%) |
| Sep 2021 | - | -$21.37 M(-6.9%) | -$91.52 M(-8.5%) |
| Jun 2021 | - | -$22.94 M(+5.9%) | -$100.04 M(-0.1%) |
| Mar 2021 | - | -$21.67 M(-15.1%) | -$100.18 M(-7.9%) |
| Dec 2020 | -$108.81 M(-365.7%) | -$25.53 M(-14.6%) | -$108.81 M(-1.1%) |
| Sep 2020 | - | -$29.89 M(+29.5%) | -$110.02 M(+6.9%) |
| Jun 2020 | - | -$23.08 M(-23.8%) | -$102.88 M(-9.3%) |
| Mar 2020 | - | -$30.30 M(+13.3%) | -$113.42 M(-377.0%) |
| Dec 2019 | $40.95 M | -$26.74 M(+17.5%) | $40.95 M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$22.75 M(-32.3%) | $42.81 M(-9.0%) |
| Jun 2019 | - | -$33.62 M(-127.1%) | $47.07 M(-17.2%) |
| Mar 2019 | - | $124.06 M(-598.8%) | $56.86 M(-381.6%) |
| Dec 2018 | -$20.19 M(-69.1%) | -$24.87 M(+34.5%) | -$20.19 M(+95.7%) |
| Sep 2018 | - | -$18.50 M(-22.4%) | -$10.32 M(+27.1%) |
| Jun 2018 | - | -$23.83 M(-150.7%) | -$8.12 M(+642.8%) |
| Mar 2018 | - | $47.00 M(-413.5%) | -$1.09 M(-98.3%) |
| Dec 2017 | -$65.33 M(+37.5%) | -$14.99 M(-8.0%) | -$65.33 M(-2.9%) |
| Sep 2017 | - | -$16.30 M(-3.0%) | -$67.30 M(+9.1%) |
| Jun 2017 | - | -$16.80 M(-2.5%) | -$61.69 M(+12.6%) |
| Mar 2017 | - | -$17.24 M(+1.6%) | -$54.80 M(+15.3%) |
| Dec 2016 | -$47.51 M(-218.0%) | -$16.96 M(+58.6%) | -$47.51 M(+18.1%) |
| Sep 2016 | - | -$10.69 M(+7.9%) | -$40.23 M(+10.1%) |
| Jun 2016 | - | -$9.91 M(-0.4%) | -$36.55 M(+7.1%) |
| Mar 2016 | - | -$9.95 M(+2.8%) | -$34.12 M(-184.7%) |
| Dec 2015 | $40.27 M(-370.2%) | -$9.68 M(+38.1%) | $40.27 M(-19.4%) |
| Sep 2015 | - | -$7.01 M(-6.3%) | $49.95 M(-12.3%) |
| Jun 2015 | - | -$7.48 M(-111.6%) | $56.96 M(-11.6%) |
| Mar 2015 | - | $64.44 M | $64.44 M |
| Dec 2014 | -$14.91 M | - | - |
FAQ
- What is Voyager Therapeutics annual free cash flow?
- What is the all time high annual FCF for Voyager Therapeutics?
- What is Voyager Therapeutics annual FCF year-on-year change?
- What is Voyager Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly FCF year-on-year change?
- What is Voyager Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Voyager Therapeutics?
- What is Voyager Therapeutics TTM FCF year-on-year change?
What is Voyager Therapeutics annual free cash flow?
The current annual FCF of VYGR is $74.66 M
What is the all time high annual FCF for Voyager Therapeutics?
Voyager Therapeutics all-time high annual free cash flow is $74.66 M
What is Voyager Therapeutics annual FCF year-on-year change?
Over the past year, VYGR annual free cash flow has changed by +$89.66 M (+597.75%)
What is Voyager Therapeutics quarterly free cash flow?
The current quarterly FCF of VYGR is -$28.23 M
What is the all time high quarterly FCF for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly free cash flow is $124.06 M
What is Voyager Therapeutics quarterly FCF year-on-year change?
Over the past year, VYGR quarterly free cash flow has changed by -$3.71 M (-15.14%)
What is Voyager Therapeutics TTM free cash flow?
The current TTM FCF of VYGR is -$28.66 M
What is the all time high TTM FCF for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM free cash flow is $91.35 M
What is Voyager Therapeutics TTM FCF year-on-year change?
Over the past year, VYGR TTM free cash flow has changed by -$103.33 M (-138.39%)